To qualify, a person must be enrolled in a Medicare Part D plan and meet one of three clinical criteriaassessed at the time you first started GLP-1 therapy, not at the time you apply: BMI of 35 or higher (no additional diagnosis required) BMI of 30 or higher, plus a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension on two or more blood pressure medications, or chronic kidney disease stage 3a or higher BMI of 27 or higher, plus a diagnosis of pre-diabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease Your provider submits a prior authorization request attesting you meet the criteriayou dont need to opt in or take any action yourself
[DOI] [PubMed] [Google Scholar] Kaminker I
PMCID: PMC11863255
Types of Cases Being Filed Current GLP-1 filings and investigations generally fall into these categories: Severe GI motility injuries (gastroparesis, bowel obstruction) Pancreatitis (acute and recurring) Kidney injury and kidney failure (often dehydration-related) Gallbladder disease and gallbladder removal Permanent or long-term digestive disability Vision Loss & Blindness Claims (NAION) Vision loss claims are not grouped with GI injury cases and are proceeding under a distinct MDL structure
( Allure editors have yet to test anything from DUA, by the way, so we cant confirm yet whether the products live up to these claims.) DUAs formulas clearly aim to target other skin-care concerns of todays youth, including premature aging and post-acne marks, as its product pages state
